JMCR Partners is the famous VC, which was founded in 2013. The leading representative office of defined VC is situated in the Shanghai. The fund was located in Asia if to be more exact in China.
The typical startup value when the investment from JMCR Partners is 1-5 millions dollars. The top amount of exits for fund were in 2019. Opposing the other organizations, this JMCR Partners works on 4 percentage points more the average amount of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The important activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.
The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Tekeluo Biotech, Viva Biotech, Riparian Pharmaceuticals. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The typical case for the fund is to invest in rounds with 3-4 participants. The meaningful sponsors for the fund in investment in the same round are Yingqi Investment, Xiamen Changrong Investment Management, Viva BioInnovator.
|Altivia Ventures||Brazil, São Paulo, Sao Paulo|
|BTU Protocol Ecosystem Fund||New York, New York, United States|
|Chemical Angel Network||Houston, Texas, United States|
|Elevate Capital||Oregon, Portland, United States|
|GROWWS||Czechia, Prague, Prague|
|Integrated Networks||Ar Riyad, Riyadh, Saudi Arabia|
|Inter National Bank||Mcallen, Texas, United States|
|Johnsonville Sausage||United States, Watertown, Wisconsin|
|Newable||England, London, United Kingdom|
|Next Orbit Ventures Fund-I||India, Maharashtra, Mumbai|
|Rock River Capital Partners||Madison, United States, Wisconsin|
|Sanden||Gunma Prefecture, Isesaki, Japan|
|Shanghai Yijinghui Asset Management||China, Shanghai|
|StartVenture||California, San Francisco, United States|
|Suzhou Xiangtang Venture Capital||China, Jiangsu, Suzhou|
|Zhong Zao Weilai||Beijing, Beijing, China|
Clues Therapeutics Inc.
|$1M||20 Jul 2020||-|
|$12M||01 Jul 2020||Cambridge, Massachusetts, United States|
|$5M||18 May 2020||Belgium, Liège, Belgium|
ProvivaÂ Therapeutics,Â Inc
|02 Jan 2020||-|
|$10M||26 Sep 2019||Shanghai, China|
|$14M||28 Jun 2019||Cambridge, Massachusetts, United States|
|$3M||12 Oct 2018||Boston, Massachusetts, United States|
Clues Therapeutics Inc.
|$800K||10 Sep 2018||-|
|$72M||08 Aug 2018||Massachusetts, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.